Research Library — Safety | Reta Compare

6 research articles in Safety. Page 1 of 1.

Articles

• Safety Considerations for Glucagon Receptor Agonism in Quad Drugs
• Safety Considerations for the Amylin Component in Quad-Agonists
• Safety Considerations for FGF21 Pathway Activation in Obesity Treatment
• Hypoglycemia Risk in Multi-Receptor Agonist Therapy
• GI Side Effects in Quad-Agonist GLP Drugs: Expectations for Improvement
• Discontinuation and Weight Regain With Next-Gen GLP Drugs